Page last updated: 2024-08-24

allicin and Cancer of Pancreas

allicin has been researched along with Cancer of Pancreas in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, J; Shen, DW; Tang, L; Wang, C; Wang, CJ; Wang, YK; Xu, RH; Zhang, H; Zhao, Y1
Akbarsha, MA; Chhabria, SV; Desai, KB; Kharkar, PS; Li, AP1

Other Studies

2 other study(ies) available for allicin and Cancer of Pancreas

ArticleYear
Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer.
    Molecular biology reports, 2013, Volume: 40, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disulfides; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Lymphocyte Count; Mice; Pancreatic Neoplasms; Recombinant Proteins; Sulfinic Acids; Survival Analysis; T-Lymphocyte Subsets; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2013
In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic changes, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expression.
    Apoptosis : an international journal on programmed cell death, 2015, Volume: 20, Issue:10

    Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Apoptosis; Carbon-Sulfur Lyases; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor Proteins; Disulfides; DNA Damage; Epigenesis, Genetic; Gene Expression; Humans; Oxidative Stress; Pancreatic Neoplasms; Reactive Oxygen Species; Sulfinic Acids; Tubulin

2015